Stevanato Group S.p.A.

NYSE STVN

Stevanato Group S.p.A. Price to Sales Ratio (P/S) on December 30, 2024: 4.94

Stevanato Group S.p.A. Price to Sales Ratio (P/S) is 4.94 on December 30, 2024, a -22.80% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Stevanato Group S.p.A. 52-week high Price to Sales Ratio (P/S) is 7.79 on February 05, 2024, which is 57.57% above the current Price to Sales Ratio (P/S).
Stevanato Group S.p.A. 52-week low Price to Sales Ratio (P/S) is 3.86 on June 24, 2024, which is -21.92% below the current Price to Sales Ratio (P/S).
Stevanato Group S.p.A. average Price to Sales Ratio (P/S) for the last 52 weeks is 5.33.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NYSE: STVN

Stevanato Group S.p.A.

CEO	Mr. Franco Stevanato
IPO Date	July 16, 2021
Location	Italy
Headquarters	Via Molinella, 17
Employees	5,635
Sector	Health Care
Industries Pharmaceuticals

Description

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.

Key trends

Past 5 years